Tag: OREX

Blue Horseshoe Stocks: Earnings Calls, Bottom-Plays & More


Momo, Inc. MOMO

We began tracking MOMO on Friday after noticing the stock coming off of a bottom, and we’ve seen an appreciable move to the upside in the ensuing sessions.

The stock is gapping up this morning on a strong earnings report (>>View Highlights), reaching a high of 12.73 in the premarket. We caught MOMO at a low of 11.52 on Friday and have thus far seen an 11% increase, so we’ll want to leave it on the radar and watch for higher lows and higher highs.

NQ Mobile, Inc. NQ

Speaking of earnings plays, we’re going to be tracking NQ closely over the next couple of sessions. The stock has been trending off of a bottom for the past three sessions and this morning, we’re seeing the stock gap up considerably.

Things are likely to get interesting as the company is slated to release earnings post-market today, and a big PR hit wires just an hour ago.

Today’s News: NQ Mobile Inc. Enters into a Definitive Agreement for the FL Mobile Divestment (>>View PR)

Hercules Offshore, Inc. HERO

We’re also going to be monitoring HERO, which, like the aforementioned stock, has been establishing a solid move up off of recently-registered two-month lows.

As you can see on the included snapshot of the chart, HERO went on a massive run from the .70-range to more than 4.00 from February to April. Indicators are ripening for what could be the next big leg up after the recent consolidation, so we’ll be sure to keep an eye peeled for the possibility of a continued upsurge.

The Children’s Place, Inc. PLCE

PLCE is yet another bottom-bouncer with earnings that is gapping up in early trading. We’re going to signal a range of options contracts for observation to possibly take advantage of the momentum. Our target range is going to be the PLCE Weekly $70-75 Calls.

Chatroom Call:

Our daily live traders chats are a great way to get involved with what we do. Regular participant DJ spotted another big runner and shared with the room shortly after the opening bell. We saw it at .03 before it went on a monumental run to hit a high of .465 on news with TOMS Shoes. Gains of over 1500% were possible. Feel free to join our traders chats by sending a Skype request to user ‘stocksumo’.

Extended Watchlist:
AMMX, ONCI, KGNX, OREX, LIVE, KGJI

Blue Horseshoe Stocks: ADTM, THCZ & More

Adaptive Medias, Inc. ADTM

We highlighted ADTM several weeks ago on January 28th, and on that day we witnessed a low of 1.58. Over the course of the following month, the stock would gradually make its way to a high of 3.10 (March 4th). That was quite a substantial run, topping out at an increase of 96%

It took another eight sessions for ADTM to come down off of those highs and find support, which it did at 2.00 last Thursday. Since then it has been registering higher lows, and yesterday reached back to a PPS high of 2.41 (+20%), so we’re going to re-radar the stock and keep watch over it into next week.

Totally Hemp Crazy, Inc. THCZ

Another high-performance stock that we first came across a few months back was THCZ. We found this gem back on December 18th and it made a 38% gain for us that day as it ran from .013-.018, but the fun certainly wasn’t over.

It took about six weeks of essentially trading sideways before THCZ would begin one of the most epic runs we’ve seen from a cannabis related play since the ‘Green Rush’ of early 2014. It culminated in a new high during Wednesday’s session, with shares changing hands for as much as .14. That represents a massive spike from the lows we observed in late December totaling 977%

At this point, we’ll be watching to see where THCZ finds support again, where we’ll be waiting for the possibility of a bounce-play on the subsequent rebound. The company put out a fresh PR this morning as well.

Totally Hemp Crazy Inc. Orders Second Production Run in April of Rocky Mountain High Hemp Infused Beverages (Fri 8:00AM EDT)

Amarantus Bioscience Holdings, Inc. AMBS

We also want to make note of AMBS as the week draws to a close. We have an extensive history with this play, and we re-flagged it on Monday morning as a “Bottom-Watch” play. The ultimate low would come across the tape at the beginning of yesterday’s session at .05 before AMBS began to bounce back.

It reached its way back to .0595 (+18%) and closed there. Moving forward, we’re going to be looking for AMBS to register higher highs and higher lows off of its bottom. The stock was trading as high as .086 at the beginning of this month, and a return to that area from current levels would spell gains on the order of 40%
____

SIDE NOTE: Speaking of stocks on bottom-watch, we want to call attention to Ohr Pharmaceuticals, Inc. OHRP. The company announced this morning that it had failed to meet its goals in a Phase II study of its OHR-102 drug, and got absolutely crushed in premarket trading down to a low of 2.68. It has recovered slightly, and we’re going to have an eye on OHRP as the session kicks off. The rebound off of such a downturn could be significant.

Extended Watchlist:
RHT, BBRY, OREX, LIVE, VJET

Blue Horseshoe Stocks: Pharma Watchlist & More

Lexicon Pharmaceuticals, Inc. LXRX

We’re taking notice of LXRX this morning in the wake of a premarket PR that has the stock trending up to its highest levels of the past three months; it contained updates on current projects as well as increased earnings. The addition of an interesting setup on the chart gives us good reason to place LXRX on watch this mid-week.

As you can see on the snapshot below, the stock gapped down significantly at the end of November. In premarket activity today we’re seeing a partial fill taking place. We’re going to be watching for LXRX to fill the remainder of the gap into the mid 1.20’s where its next area of resistance will come in at the 200DMA of 1.28.

THE WOODLANDS, Texas, March 4, 2015 /PRNewswire/ — Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three months and year ended December 31, 2014.>> VIEW PR

Pharmaceutical Watchlist

There are a number of other pharma and biopharma stocks gapping up in the premarket this morning, some of which have appeared in our reports in the past. We’ve listed them below along with links to today’s news, where applicable:

Keryx Biopharmaceuticals, Inc. KERX


Atossa Genetics, Inc. ATOS


Coronado Biosciences, Inc. CNDO

Coronado Biosciences Forms New Subsidiary, Checkpoint Therapeutics, to Develop Novel Immuno-Oncology Antibodies (Wed 8:30AM EST)

PhotoMedex, Inc. PHMD

Orexigen Therapeutics, Inc. OREX

KaloBios Pharmaceuticals, Inc. KBIO

Earnings-Related Options Ideas

American Eagle Outfitters, Inc. AEO beat expected Q4 profits and revenues, and is gapping up as a result. To take advantage of the trend, we are monitoring options trading possibilities in the AEO Weekly $15-16 Calls

Abercrombie & Fitch ANF fell short of expectations with regard to sales, which is fueling a downtrend here in the premarket, so we’ll take the opposite approach here, and keep an eye on ANF Weekly $23-24 Puts.

Extended Watchlist:
IFON, PLUG, NPTN, WLT, LEI